Skip to main content
  • AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study

    AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study

    Company’s trial will evaluate safety and efficacy of its Pulse IVL system in patients with severely calcified peripheral arterial disease

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details